openPR Logo
Press release

Rapid RNA testing kits Market Report Explored in Latest Research 2018 - 2028

01-07-2019 12:26 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Future Market Insights

Rapid RNA testing kits Market Report Explored in Latest Research

The objective of designing rapid RNA testing kits is to have high sensitivity with low cost, faster results and easy to use. Most of these rapid RNA testing kits give results in a short time frame (~1 hour). Some of the rapid RNA testing kits such as the TruTip Rapid RNA Kit by Akonni Biosystems, Inc. are available in different configurations specific to the viscosity of the sample used i.e. low viscosity and high viscosity. These rapid RNA testing kits are used for both research as well as for diagnosis of a number of infections and diseases. The rapid RNA testing kits act as point of care testing kits for infections such as HIV, Influenza and others.

The use of rapid RNA testing kits is very useful in regions where the pathology services are not well resourced as well as in low economic regions such as Africa. Initiatives of WHO to reduce the number of HIV cases globally support the growth of rapid RNA testing kits for HIV. Rise of other infectious diseases such as influenza is another concern that requires fast testing to ensure timely diagnosis and treatment. These rapid RNA testing kits generally use urine or blood samples. In some cases saliva is also used as sample source for rapid RNA testing kits.

Request to Sample of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8099

The rapid RNA testing kits require to undergo regulatory approvals. FDA in North America regulates the rapid RNA testing kits in order to maintain quality of the products. In Europe the European Medicines Agency, CFDA in China, Therapeutic Goods Administration (TGA) in Australia and Pharmaceuticals and Medical Devices Agency (PMDA) in Japan regulate the rapid RNA testing kits in their respective markets.

Rapid RNA testing kits Market: Drivers and Restraints

Increase in research in the biotechnology industry as well as rise in certain diseases and infections such as HIV and influenza drive the growth of the Rapid RNA testing kits market significantly. Ease of use of rapid RNA testing kits, as well as faster results is supporting the growing popularity of the rapid RNA testing kits market. Availability of low cost alternative methods may hinderer the growth of the market during the forecast period.

Rapid RNA testing kits Market: Segmentation

The global Rapid RNA testing kits market is segmented by product type, end user and region:

Based on product type, the global Rapid RNA testing kits market is segmented into:

Adenovirus testing kits
Herpes Virus I testing kits
Influenza A & B
Others

Based on end user, the global Rapid RNA testing kits market is segmented into:

Pharmaceutical & Biotech Companies
Diagnostic Centers
Academic & Research Institutions

Rapid RNA testing kits Market: Overview

Rapid RNA testing kits market is anticipated to grow with a significant growth rate over the forecast period 2018-2028. Rapid RNA testing kits are used for research as well as for diagnosis. Rapid RNA testing kits generally can be categories based on the type of RNA being tested, such as adenovirus testing kits, Herpes Virus I testing kits, Influenza A&B testing kits and others. Based on the end user, Rapid RNA testing kits market is segmented into pharmaceutical and biotech companies, diagnostic centers and academic & research institutes.

Rapid RNA testing kits Market: Regional Outlook

On the basis of geography, the global Rapid RNA testing kits market is segmented into eight key regions, namely North America, Latin America, Western Europe, Eastern Europe, the Asia Pacific excluding China, and Japan, China, Japan, and Middle East & Africa. The Rapid RNA testing kits market in North America is expected to hold maximum market share in the global Rapid RNA testing kits market owing to the supportive healthcare system in the region. Rapid RNA testing kits market in Asia Pacific is anticipated to grow at a rapid pace with the maximum CAGR over the forecast period due to strong and evolving government support towards research and healthcare in the region.

Request Report for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-8099

Rapid RNA testing kits Market: Key Players

Some of the key players in the global Rapid RNA testing kits market are GeneBio Systems Inc., Akonni Biosystems, Inc., Zymo Research, Bioo Scientific, MP Biomedicals, LLC., ThermoFisher Scientific and others. The Rapid RNA testing kits market is fragmented market with a number of players in China and U.S. dominating the global Rapid RNA testing kits market.

About Us
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Web: https://www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rapid RNA testing kits Market Report Explored in Latest Research 2018 - 2028 here

News-ID: 1475194 • Views:

More Releases from Future Market Insights

Global Olive Stone Coffee and Beverage Roasts Market to Reach USD 1,620 Million by 2036 as Sustainable Specialty Brewing Gains Momentum
Global Olive Stone Coffee and Beverage Roasts Market to Reach USD 1,620 Million …
The global olive stone coffee and beverage roasts market is entering a high-growth decade, fueled by sustainability innovation and evolving specialty coffee culture. Valued at USD 510 million in 2026, the market is projected to reach USD 1,620 million by 2036, expanding at a compelling CAGR of 11.5%. As consumers increasingly seek beverages that combine sustainability, functionality, and distinctive taste, olive stone-based roasting solutions are transitioning from niche experimentation to structured
Japan Dried Spent Grain Market to Surpass USD 1.1 Billion by 2036 as Feed Optimization and Fiber-Rich Food Innovation Sustain Growth
Japan Dried Spent Grain Market to Surpass USD 1.1 Billion by 2036 as Feed Optimi …
Japan's dried spent grain market is entering a decade of steady, value-driven expansion, supported by structured feed demand, brewery byproduct utilization, and rising integration of fiber-rich ingredients into food manufacturing. Industry estimates place the market at USD 784.8 million in 2026, with projections indicating growth to USD 1,109.4 million by 2036, reflecting a CAGR of 3.5%. Between 2020 and 2026, demand increased from USD 637.5 million to USD 784.8 million, shaped
USA Food Grade Titanium Dioxide Market to Reach USD 7.3 Million by 2036 Amid Steady Regulatory-Aligned Demand
USA Food Grade Titanium Dioxide Market to Reach USD 7.3 Million by 2036 Amid Ste …
The demand for food grade titanium dioxide in the USA is valued at USD 4.9 million in 2026 and is projected to reach USD 7.3 million by 2036, expanding at a CAGR of 4.1%. Growth remains moderate yet stable, supported by continued use of titanium dioxide as a whitening and opacifying agent across confectionery coatings, bakery decorations, sauces, dairy analogues, and processed food matrices. Despite heightened regulatory scrutiny and evolving clean-label
USA Partially Hydrogenated Oil Market to Reach USD 529.4 Million by 2036 Amid Measured Industrial and Specialty Food Demand
USA Partially Hydrogenated Oil Market to Reach USD 529.4 Million by 2036 Amid Me …
The demand for partially hydrogenated oil in the USA is projected to rise from USD 309.6 million in 2026 to USD 529.4 million by 2036, expanding at a steady CAGR of 5.5%. While edible applications remain tightly regulated, demand persists across specialty industrial and permitted food-related segments where oxidative stability, viscosity control, and texture performance remain critical. Despite regulatory constraints on trans fats in conventional food manufacturing, PHOs continue to serve

All 5 Releases


More Releases for RNA

CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes. CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic,
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032. This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through - • 70% efforts of Primary Research • 15% efforts of Secondary Research • 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate? • The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%. • Expected exponential
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032. The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may